Estrade
  • Finance
  • Real Estate
  • Tech
  • Education
  • Lifestyle & Leisure
  • Estrade Awards
No Result
View All Result
Estrade
  • Finance
  • Real Estate
  • Tech
  • Education
  • Lifestyle & Leisure
  • Estrade Awards
No Result
View All Result
Estrade
No Result
View All Result
Home Hot News

Elekta showcases Evo, its AI-powered, online adaptive CT-Linac at the Association of Medical Physicists of India – National Congress 2025 (AMPICON) in Guwahati

Team Estrade by Team Estrade
December 10, 2025
in Hot News, Technology
0
Elekta Evo Launch In India

Elekta Evo Launch In India

Share on FacebookShare on Twitter

Evo features high-definition image quality and online adaptive radiotherapy capabilities for treating cancer

GUWAHATI, India , Dec. 5, 2025 /PRNewswire/ — Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo is now available in India, bringing high-definition AI-enhanced imaging and its adaptive radiation therapy capabilities to clinicians across the country. This highly versatile CT-Linac will enable clinicians to choose the most suitable radiation therapy technique for each individual patient.

Evo was showcased for the first time in India at the Association of Radiation Oncologists of India Conference (AROICON) in Kolkata on November 29th and then again at the Annual National Conference of the Association of Medical Physicists of India (AMPICON) in Guwahati on December 04th.

Feras Al Hasan, Head of TIMEA, Elekta said : ” We are delighted to bring our flagship innovation Evo Elekta to India. Evo brings a new level of flexibility to India’s radiotherapy landscape and is designed to help centres deliver more personalized, efficient care. Its ability to support both online and offline adaptive treatments on a CT-Linac gives clinicians the confidence to adjust therapy based on daily anatomical changes which is especially important in India, where many patients present with complex and advanced stage diseases. Our aim is to strengthen Elekta’s commitment to making high-quality cancer treatment accessible to more patients across the globe.”

Related Post

QFocus Technologies Scales Global Engineering Business, Plans to Triple Workforce in 2027 to Support Growing Customer Demand

QFocus Technologies: Plans to Triple Workforce by 2027 to Meet Demand

October 23, 2026

Silverpush: Wins Big at Cannes Lions 2026

July 29, 2026

Marvell: Invests $250 Million in India

July 29, 2026

Manipal University Jaipur: Collaborates on AI-Driven Agricultural Innovation

July 11, 2026

Shankar Seshadri, VP & Head – India Sub-continent, Elekta added: “India needs radiotherapy solutions that combine precision with practicality and Evo is uniquely positioned to address India’s growing cancer burden and evolving patient needs. Its adaptive capabilities and streamlined workflow help high-volume centres treat more patients without compromising treatment quality. The arrival of Evo in India marks a significant milestone, as it will help accelerate our market growth in the region.”

Adaptive radiotherapy, also known as Adaptive Radiation Therapy or ART, is a treatment approach in which the radiation plan is adjusted over the course of therapy to account for changes in a patient’s unique anatomy and or tumor. Delivering this therapy requires high-quality imaging that enables clinicians to visualize tumors and organs at risk, ensuring precise contouring. Evo helps address this need with two essential features: Iris®™ high-definition, AI-enhanced imaging, which allows visualization of target areas with greater clarity, and Elekta ONE Online** software, which brings distributed treatment planning, faster dose calculation and AI-driven automation for contouring and dose planning.

* Elekta Evo has Central Drugs Standard Control Organization (CDSCO) registration with limited global availability. **Elekta ONE® is comprised of multiple Elekta solutions, some of which may not yet be available in all markets.

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it’s personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit https://www.elekta.com

Source: PR Newswire

Donation

Buy author a coffee

Donate
Tags: ai technologycancer treatmentElektahealthcare technologymedical devicesmedical physicsoncologyradiotherapy
Team Estrade

Team Estrade

Related Posts

QFocus Technologies Scales Global Engineering Business, Plans to Triple Workforce in 2027 to Support Growing Customer Demand
Hot News

QFocus Technologies: Plans to Triple Workforce by 2027 to Meet Demand

by Team Estrade
October 23, 2026
Technology

Silverpush: Wins Big at Cannes Lions 2026

by Team Estrade
July 29, 2026
Marvell to Invest $250 Million in India, Expanding Bangalore Facility to Drive Next-generation AI Technology Development
Spotlight

Marvell: Invests $250 Million in India

by Team Estrade
July 29, 2026
Next Post
Som Chatterjee, Founder and CEO, Prismforce

Prismforce Advances Agentic AI to Transform Enterprise Talent Management

Recommended

Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award (PRNewsfoto/Innoviti Technologies Pvt. Ltd.)

Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award

December 18, 2025

Ebix Inc.: Joins NeoProEd Insurance Conclave as Gold Partner in GIFT City

September 21, 2026
India's First Women's Pro Volleyball League Builds Squads with Rs 1.5 Crore Investment

Women’s Pro Volleyball League: Launches with Rs 1.5 Crore Player Investment

October 26, 2026
Noida Expressway Emerges As Ncr Apos S Fastest Growing Luxury Housing Corridor

ANAROCK: Noida Expressway Redefines Luxury Living

June 10, 2026
SPJIMR #2 in India and #15 globally in Financial Times

S.P. Jain Institute of Management & Research (SPJIMR): Ranks No. 42 in The Case Centre Impact Index 2026

November 2, 2026
CRIF Launches Ahmedabad Chapter of ‘Credit Goes to HER’ to Advance Women’s Financial Empowerment

CRIF: Launches Ahmedabad Chapter of Credit Goes to HER for Women’s Financial Empowerment

November 2, 2026
Deakin University and CHL partner with IIT Roorkee

IIT Roorkee and Deakin University: Launch Crisis Leadership Training

November 2, 2026
30 Sundays Releases Insights on How Bali Travel Has Changed for Indian Couples

30 Sundays: Indian Couples Shift to Split Stays and Island Overnights in Bali

November 2, 2026
Estrade

We are a business news focused digital platform. Our vision is to provide a stage to businesses and corporate houses who are on a growth trajectory.

Get in Touch : info@estrade.in

Stay ahead with Estrade Business Media

Get the latest in business!


    Categories

    • Education
    • Finance
    • Hot News
    • Lifestyle & Leisure
    • Real Estate
    • Spotlight
    • Technology

    © 2025 Estrade | Engineered by WEBINEERING.

    No Result
    View All Result
    • Finance
    • Real Estate
    • Tech
    • Education
    • Lifestyle & Leisure
    • Estrade Awards

    © 2025 Estrade | Engineered by WEBINEERING.